Sponsor Pipeline

Peking University Third Hospital Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
191
Active Trials
87
Recruiting
10
Disease Areas
9
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-09 NCT06522542
Gastric Cancer Complicated With Bleeding
overall status: Not Yet Recruiting → Unknown
2026-08-02 NCT06587009
Application of Shock Wave Technique in Conservative Treatment of Rotator Cuff Tear
overall status: Recruiting → Unknown
2026-08-02 NCT06563739
Study on the Application of Shock Wave Technique After Rotator Cuff Operation
overall status: Recruiting → Unknown
2026-08-02 NCT06528639
A Clinical Study on Exercise Guided by CPET to Reduce the Risk of Metabolic…
overall status: Recruiting → Unknown
2026-08-02 NCT06512506
Prospective Cohort Study of Arthroscopic Treatment of Hip Dysplasia
overall status: Recruiting → Unknown
2026-08-02 NCT06493175
The Application of Large Language Model in Emergency Chest Pain Triage
overall status: Recruiting → Unknown
2026-07-31 NCT07453381
Multisensor Wireless Pressure Microcatheter For Microvascular Function Assessment In…
Recruitment opened
2026-07-31 NCT07453381
Multisensor Wireless Pressure Microcatheter For Microvascular Function Assessment In…
date change Primary completion pushed: 2026-09-30 -> 2026-12-31
2026-07-31 NCT07453381
Multisensor Wireless Pressure Microcatheter For Microvascular Function Assessment In…
date change Completion pushed: 2026-10-31 -> 2026-12-31
New Trial Filings, Last 30 Days
First PostedTrialPhaseStatus
2026-08-13 NCT07762144 Clinical Cohort Construction Program of Peking University Third Hospital Enrolling by Invitation
2026-08-12 NCT07760012 68Ga-SorB PET/CT Imaging in Patients With Solid Tumors Recruiting
2026-08-12 NCT07761676 The Cohort Construction Project of Peking University Third Hospital Recruiting
2026-08-10 NCT07755072 The Effect of Ligament of Marshall Excision During Minimally Invasive Cardiac… Not Yet Recruiting
2026-08-04 NCT07744633 Unplanned Return to the Operating Room in Orthopaedics: Closed-Loop Quality Improvement… Not Yet Recruiting
2026-08-03 NCT07741630 Mirvetuximab Soravtansine Combined With Suvemcitug in Platinum-Resistant Recurrent… Phase 2 Not Yet Recruiting
2026-08-03 NCT07742696 Comparison of Postoperative Functional Outcomes Between Subvastus and Medial Parapatellar… Not Yet Recruiting
Active Trials by Phase
Phase 4
8
Phase 2
10
Phase 1/2
2
Phase 1
1
Early Phase 1
3
Not specified
167
Active Trials — top 25 of 191
NCT IDTitleConditionStatus
Phase 4
NCT05923905 Clinical Study to Evaluate the Efficacy and Safety of FB1006 in the Treatment of ALS… Sporadic and Familial Amyotrophic Lateral Sclerosis Recruiting
NCT06546540 The Safety and Efficacy of Telitacicept in the Treatment of Systemic Sclerosis Systemic Sclerosis Recruiting
NCT06608992 Evaluation of the Effect of SURGICEL® Powder in TKA Knee Osteoarthritis Recruiting
NCT06742710 Liraglutide Treatment in Obese Infertile PCOS Women PCOS Recruiting
NCT07099157 Efficacy and Safety of Brivudine in the Treatment of Herpes Zoster Herpes Zoster Recruiting
NCT07319598 A Study to Test Tetrandrine Tablets for Connective Tissue Disease-Related Lung Disease Interstitial Lung Disease (ILD) Recruiting
NCT07020559 Allogeneic vs Autologous PRP for Diabetic Wounds in Renal Dysfunction: a Randomized… Diabetic Wounds Not Yet Recruiting
NCT07704190 Effect of Secukinumab on Cardiorenal Outcomes in Patients With Cardiorenal Metabolic… Cardiorenal Metabolic Syndrome Not Yet Recruiting
Phase 2
NCT04834544 A Study of Maintenance DCVAC/OvCa After First-line Chemotherapy Added Standard of Care Epithelial Ovarian Carcinoma Recruiting
NCT05924373 Human Dental Pulp Mesenchymal Stem Cells for the Treatment of Chronic Periodontitis… Periodontitis Recruiting
NCT06792162 PD-1 Antibody Carilizumab Combined with Apatinib for Unresectable Stage III and IV DMMR… Gastric Cancer Recruiting
NCT07460362 Glofitamab Combined With Lenalidomide in High Risk Patients With Relapsed or Refractory… MCL Recruiting
NCT07647289 EV + Toripalimab vs GC as Neoadjuvant Therapy in Locally Advanced/High-Risk MIBC Muscle-Invasive Bladder Cancer (MIBC) Recruiting
NCT06009029 SBRT Combined With Zimberelimab (GLS-010) in Locally Advanced Pancreatic Cancer (SPARK-1… Locally Advanced Pancreatic Cancer Not Yet Recruiting
NCT06426056 Nab-Paclitaxel Plus Cisplatin With Concurrent Radiotherapy for Patients With Locally… Cervical Cancer Not Yet Recruiting
NCT07339553 Clinical Study of EZH2 Inhibitor Combined With PARP Inhibitor in the Treatment of… Ovariancancer Not Yet Recruiting
NCT07412171 NECTAR Study: Neoadjuvant Toripalimab + 9MW2821 for Local UTUC Upper Tract Urothelial Carcinoma Not Yet Recruiting
NCT07741630 Mirvetuximab Soravtansine Combined With Suvemcitug in Platinum-Resistant Recurrent… PROC Not Yet Recruiting
Phase 1/2
NCT06828042 Safety and Efficacy of Universal CD19-targeting CAR-γδT Cells in Refractory Autoimmune… Systemic Lupus Erthematosus Recruiting
NCT06821659 Safety and Efficacy of Universal CAR-T Cells (UWD-CD19) Combined with Immunosuppressants… Systemic Lupus Erthematosus Not Yet Recruiting
Phase 1
NCT04595162 A Study of GC019F CAR-T Cell Immunotherapy for Relapsed or Refractory B- ALL B-cell Acute Lymphoblastic Leukemia Not Yet Recruiting
Early Phase 1
NCT06645197 An IIT Clinical Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of a… Amyotrophic Lateral Sclerosis (ALS) Not Yet Recruiting
NCT06819358 Individualized Functional Imaging-Guided Repetitive Transcranial Magnetic Stimulation… Amyotrophic Lateral Sclerosis (ALS) Not Yet Recruiting
NCT07301164 Clinical Study of BCT301 Cell Injection Therapy for Refractory Autoimmune Diseases System Lupus Erythematosus Not Yet Recruiting
Not specified
NCT04454892 Natural History and Clinical Features of Amyotrophic Lateral Sclerosis (ALS) Amyotrophic Lateral Sclerosis Recruiting
See all 191 active Peking University Third Hospital trials with filters →
Disease Areas
Get alerts when Peking University Third Hospital's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free